RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+139.82%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$3.3B
AUM Growth
+$3.3B
(+96%)
Cap. Flow
+$632M
Cap. Flow
% of AUM
19.16%
Top 10 Holdings %
Top 10 Hldgs %
71.48%
Holding
41
New
9
Increased
7
Reduced
2
Closed
7
Top Buys
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$127M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$114M |
| 3 |
89bio
ETNB
|
$83.1M |
| 4 |
Arvinas
ARVN
|
$82.6M |
| 5 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$76.1M |
Top Sells
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$35.3M |
| 2 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$32.1M |
| 3 |
Axsome Therapeutics
AXSM
|
$30.7M |
| 4 |
Precision BioSciences
DTIL
|
$15.5M |
| 5 |
Kodiak Sciences
KOD
|
$14.7M |
Sector Composition
| 1 | Healthcare | 95.85% |
| 2 | Technology | 0% |
